Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome

Identifieur interne : 003182 ( PascalFrancis/Corpus ); précédent : 003181; suivant : 003183

Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome

Auteurs : H. S. Singer ; A. Krumholz ; J. Giuliano ; L. S. Kiessling

Source :

RBID : Pascal:97-0489611

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 12
A06       @2 5
A08 01  1  ENG  @1 Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome
A11 01  1    @1 SINGER (H. S.)
A11 02  1    @1 KRUMHOLZ (A.)
A11 03  1    @1 GIULIANO (J.)
A11 04  1    @1 KIESSLING (L. S.)
A14 01      @1 Department of Neurology, Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut.
A14 02      @1 Department of Pediatrics, Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 1 aut.
A14 03      @1 Departments of Pediatrics and Family Medicine, Brown University @2 Providence, Rhode Island @3 USA @Z 4 aut.
A20       @1 738-742
A21       @1 1997
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000069259610170
A44       @0 0000 @1 © 1997 INIST-CNRS. All rights reserved.
A45       @0 44 ref.
A47 01  1    @0 97-0489611
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Gilles de la Tourette syndrome @5 01
C03 01  X  ENG  @0 Gilles de la Tourette syndrome @5 01
C03 01  X  SPA  @0 Gilles de la Tourette síndrome @5 01
C03 02  X  FRE  @0 Phospholipide @5 04
C03 02  X  ENG  @0 Phospholipid @5 04
C03 02  X  SPA  @0 Fosfolípido @5 04
C03 03  X  FRE  @0 Diphosphatidylglycérol @5 07
C03 03  X  ENG  @0 Diphosphatidylglycerol @5 07
C03 03  X  SPA  @0 Difosfatidilglicerol @5 07
C03 04  X  FRE  @0 Anticoagulant @5 10
C03 04  X  ENG  @0 Anticoagulant @5 10
C03 04  X  SPA  @0 Anticoagulante @5 10
C03 05  X  FRE  @0 Lupus @5 11
C03 05  X  ENG  @0 Lupus @5 11
C03 05  X  SPA  @0 Lupus @5 11
C03 06  X  FRE  @0 Anticorps @5 13
C03 06  X  ENG  @0 Antibody @5 13
C03 06  X  SPA  @0 Anticuerpo @5 13
C03 07  X  FRE  @0 Exploration @5 17
C03 07  X  ENG  @0 Exploration @5 17
C03 07  X  SPA  @0 Exploración @5 17
C03 08  X  FRE  @0 Enfant @5 20
C03 08  X  ENG  @0 Child @5 20
C03 08  X  SPA  @0 Niño @5 20
C03 09  X  FRE  @0 Adolescent @5 21
C03 09  X  ENG  @0 Adolescent @5 21
C03 09  X  SPA  @0 Adolescente @5 21
C07 01  X  FRE  @0 Homme
C07 01  X  ENG  @0 Human
C07 01  X  SPA  @0 Hombre
C07 02  X  FRE  @0 Système nerveux pathologie @5 37
C07 02  X  ENG  @0 Nervous system diseases @5 37
C07 02  X  SPA  @0 Sistema nervioso patología @5 37
C07 03  X  FRE  @0 Système nerveux central pathologie @5 38
C07 03  X  ENG  @0 Central nervous system disease @5 38
C07 03  X  SPA  @0 Sistema nervosio central patología @5 38
C07 04  X  FRE  @0 Encéphale pathologie @5 39
C07 04  X  ENG  @0 Cerebral disorder @5 39
C07 04  X  SPA  @0 Encéfalo patología @5 39
C07 05  X  FRE  @0 Maladie dégénérative @5 40
C07 05  X  ENG  @0 Degenerative disease @5 40
C07 05  X  SPA  @0 Enfermedad degenerativa @5 40
N21       @1 300

Format Inist (serveur)

NO : PASCAL 97-0489611 INIST
ET : Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome
AU : SINGER (H. S.); KRUMHOLZ (A.); GIULIANO (J.); KIESSLING (L. S.)
AF : Department of Neurology, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut., 2 aut., 3 aut.); Department of Pediatrics, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut.); Departments of Pediatrics and Family Medicine, Brown University/Providence, Rhode Island/Etats-Unis (4 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1997; Vol. 12; No. 5; Pp. 738-742; Bibl. 44 ref.
LA : Anglais
CC : 002B17G
FD : Gilles de la Tourette syndrome; Phospholipide; Diphosphatidylglycérol; Anticoagulant; Lupus; Anticorps; Exploration; Enfant; Adolescent
FG : Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Maladie dégénérative
ED : Gilles de la Tourette syndrome; Phospholipid; Diphosphatidylglycerol; Anticoagulant; Lupus; Antibody; Exploration; Child; Adolescent
EG : Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Degenerative disease
SD : Gilles de la Tourette síndrome; Fosfolípido; Difosfatidilglicerol; Anticoagulante; Lupus; Anticuerpo; Exploración; Niño; Adolescente
LO : INIST-20953.354000069259610170
ID : 97-0489611

Links to Exploration step

Pascal:97-0489611

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome</title>
<author>
<name sortKey="Singer, H S" sort="Singer, H S" uniqKey="Singer H" first="H. S." last="Singer">H. S. Singer</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Pediatrics, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Krumholz, A" sort="Krumholz, A" uniqKey="Krumholz A" first="A." last="Krumholz">A. Krumholz</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Giuliano, J" sort="Giuliano, J" uniqKey="Giuliano J" first="J." last="Giuliano">J. Giuliano</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kiessling, L S" sort="Kiessling, L S" uniqKey="Kiessling L" first="L. S." last="Kiessling">L. S. Kiessling</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Departments of Pediatrics and Family Medicine, Brown University</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">97-0489611</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 97-0489611 INIST</idno>
<idno type="RBID">Pascal:97-0489611</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003182</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome</title>
<author>
<name sortKey="Singer, H S" sort="Singer, H S" uniqKey="Singer H" first="H. S." last="Singer">H. S. Singer</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Pediatrics, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Krumholz, A" sort="Krumholz, A" uniqKey="Krumholz A" first="A." last="Krumholz">A. Krumholz</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Giuliano, J" sort="Giuliano, J" uniqKey="Giuliano J" first="J." last="Giuliano">J. Giuliano</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kiessling, L S" sort="Kiessling, L S" uniqKey="Kiessling L" first="L. S." last="Kiessling">L. S. Kiessling</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Departments of Pediatrics and Family Medicine, Brown University</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Antibody</term>
<term>Anticoagulant</term>
<term>Child</term>
<term>Diphosphatidylglycerol</term>
<term>Exploration</term>
<term>Gilles de la Tourette syndrome</term>
<term>Lupus</term>
<term>Phospholipid</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Gilles de la Tourette syndrome</term>
<term>Phospholipide</term>
<term>Diphosphatidylglycérol</term>
<term>Anticoagulant</term>
<term>Lupus</term>
<term>Anticorps</term>
<term>Exploration</term>
<term>Enfant</term>
<term>Adolescent</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>12</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>SINGER (H. S.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>KRUMHOLZ (A.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>GIULIANO (J.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>KIESSLING (L. S.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Pediatrics, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Departments of Pediatrics and Family Medicine, Brown University</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>738-742</s1>
</fA20>
<fA21>
<s1>1997</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000069259610170</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>44 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>97-0489611</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Gilles de la Tourette syndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Gilles de la Tourette syndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Gilles de la Tourette síndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Phospholipide</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Phospholipid</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Fosfolípido</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Diphosphatidylglycérol</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Diphosphatidylglycerol</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Difosfatidilglicerol</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Anticoagulant</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Anticoagulant</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Anticoagulante</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Lupus</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Lupus</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Lupus</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Anticorps</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Antibody</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Anticuerpo</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Exploración</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Enfant</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Child</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Niño</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Adolescent</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Adolescent</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Adolescente</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>300</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 97-0489611 INIST</NO>
<ET>Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome</ET>
<AU>SINGER (H. S.); KRUMHOLZ (A.); GIULIANO (J.); KIESSLING (L. S.)</AU>
<AF>Department of Neurology, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut., 2 aut., 3 aut.); Department of Pediatrics, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (1 aut.); Departments of Pediatrics and Family Medicine, Brown University/Providence, Rhode Island/Etats-Unis (4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1997; Vol. 12; No. 5; Pp. 738-742; Bibl. 44 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Gilles de la Tourette syndrome; Phospholipide; Diphosphatidylglycérol; Anticoagulant; Lupus; Anticorps; Exploration; Enfant; Adolescent</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Maladie dégénérative</FG>
<ED>Gilles de la Tourette syndrome; Phospholipid; Diphosphatidylglycerol; Anticoagulant; Lupus; Antibody; Exploration; Child; Adolescent</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Degenerative disease</EG>
<SD>Gilles de la Tourette síndrome; Fosfolípido; Difosfatidilglicerol; Anticoagulante; Lupus; Anticuerpo; Exploración; Niño; Adolescente</SD>
<LO>INIST-20953.354000069259610170</LO>
<ID>97-0489611</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003182 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003182 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:97-0489611
   |texte=   Antiphospholipid antibodies : An epiphenomenon in Tourette syndrome
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024